Insights

Access our latest insights & resources

Filters

Content Type: Research

U.S. Technology & ETF Selection for Acceleration

U.S. Technology & ETF Selection for Acceleration

ETF & Mutual Fund, Research
The Information Technology sector has rebounded strongly...
Read more
European Market Strategy: Cutting to Underweight

European Market Strategy: Cutting to Underweight

Fundamental, Research
Since its downtrend bottomed at end of September 2022, the S&P Europe 350 has gained...
Read more
August PDUFA Calendar

August PDUFA Calendar

Policy & Legal, Research
August will be a busy month for FDA approvals with unofficially 22 applications...
Read more
Amazon Q2 2023 Earnings Preview: E-Commerce Efficiencies and Generative AI

Amazon Q2 2023 Earnings Preview: E-Commerce Efficiencies and Generative AI

Fundamental, Research
Amazon.com (AMZN 131 ****) will soon report Q2 2023 results.
Read more
What a Fed Rate Pause (Or Cut) Might Mean for U.S. Utilities

What a Fed Rate Pause (Or Cut) Might Mean for U.S. Utilities

Fundamental, Research
We anticipate the Federal Reserve is near the end of its current...
Read more
Durbin 2.0: Senate NDAA & Credit Routing

Durbin 2.0: Senate NDAA & Credit Routing

Policy & Legal, Research
It is déjà vu all over again: Investors should be prepared for noise renewed around...
Read more
(T, VZ, FYBR, LUMN) Telco Shares Hit by a Lead Pipe; Is it Warranted?

(T, VZ, FYBR, LUMN) Telco Shares Hit by a Lead Pipe; Is it Warranted?

Policy & Legal, Research
The recent Wall Street Journal expose’ on the dangers of lead in old, discarded...
Read more
Mountain Valley Pipeline: Emergency Petition Filed, Response Due Tuesday, July 25

Mountain Valley Pipeline: Emergency Petition Filed, Response Due Tuesday, July 25

Policy & Legal, Research
Update on the Mountain Valley Pipeline.
Read more
Shockwave (SWAV): No Higher Rates For Now

Shockwave (SWAV): No Higher Rates For Now

Policy & Legal, Research
In omitting any narrative discussion of Shockwave’s (SWAV) coronary lithotripsy device..
Read more
FDA Action on Aspartame Unlikely

FDA Action on Aspartame Unlikely

Policy & Legal, Research
Recent reports that the World Health Organization (WHO) will reclassify aspartame...
Read more